30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
Karuna Therapeutics Inc. (KRTX)
This company is not actively trading or the ticker does belong to another company in our database now.
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Taconic Capital Frank Brosens | 0 | $0 | 0% | |
| 2. | Farallon Capital Thomas Steyer | 0 | $0 | 0% | |
| 3. | HBK Investments David Costen Haley | 0 | $0 | 0% | |
| 4. | Squarepoint Ops LLC Maxime Fortin (Cio) | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $123.39 | 24,161 | $2,981,225.79 | 2,072,441 | 2022-06-30 | Filing | |
| $122.27 | 48,062 | $5,876,540.74 | 2,048,280 | 2022-06-30 | Filing | |
| $125.00 | 9,129 | $1,141,125.00 | 2,000,218 | 2022-06-29 | Filing | |
| $124.73 | 6,832 | $852,155.36 | 1,991,089 | 2022-06-29 | Filing | |
| $122.95 | 4,039 | $496,595.05 | 1,984,257 | 2022-06-29 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $318.96 | 100 | $31,896.00 | 42,604 | 2024-03-08 | Filing | |
| $318.33 | 4,900 | $1,559,817.00 | 42,704 | 2024-03-08 | Filing | |
| $316.56 | 818 | $258,946.08 | 41,150 | 2024-02-08 | Filing | |
| $316.05 | 4,182 | $1,321,721.10 | 41,968 | 2024-02-08 | Filing | |
| $316.81 | 15,000 | $4,752,150.00 | 38,650 | 2024-01-08 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% |
News See All
Bronte Amalthea Fund Incurred Loss in Karuna Therapeutics (KRTX) Short Position
Bronte Capital, an investment management company, released its “Amalthea Fund” fourth-quarter 2023 investor letter. A copy of the same can be downloaded here.
Karuna Therapeutics (KRTX) Rose on Acquisition Announcement
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” fourth quarter 2023 investor letter. A copy of the same can be downloaded here.
Karuna Therapeutics, Inc. (NASDAQ:KRTX) Q3 2023 Earnings Call Transcript
Operator: Welcome to the Karuna Therapeutics Third Quarter 2023 Financial Results Conference Call. All participants are in a listen-only mode. Please note, this call is being recorded.
What Makes Karuna Therapeutics (KRTX) a Prospective Investment?
ClearBridge Investments, an investment management company, released its “ClearBridge SMID Cap Growth Strategy” second quarter 2023 investor letter. A copy of the same can be downloaded here.
5 Best High Risk High Reward Stocks To Buy Now
In this piece, we will take a look at the five best high risk high reward stocks to buy now.
10 Oversold Healthcare Stocks to Buy
In this article, we will take a look at the 10 healthcare stocks to buy.
Karuna Therapeutics, Inc. (NASDAQ:KRTX) Q2 2023 Earnings Call Transcript
Operator: Welcome to the Karuna Therapeutics Second Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please note that this call is being recorded.
Karuna Therapeutics, Inc. (NASDAQ:KRTX) Q1 2023 Earnings Call Transcript
Operator: Welcome to the Karuna Therapeutics First Quarter 2023 Financial Results Conference Call. All participants are in a listen-only mode. Please note this call is being recorded.
11 Best Mid-Cap Healthcare Stocks To Buy Now
The healthcare industry outlook is currently uncertain due to a combination of factors such as economic troubles, a shortage of healthcare workers, and the ongoing COVID-19 pandemic.